Enmanuelle Pardilla-Delgado

Enmanuelle Pardilla-Delgado

Auto-generated profile, based on publicly available information

Enmanuelle Pardilla-Delgado

Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital and Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JAJoseph F. Arboleda-Velasquez
Joseph F. Arboleda-Velasquez
FLFRANCISCO LOPERA
FRANCISCO LOPERA
MOMichael O’hare
Michael O’hare
SDSantiago Delgado-Tirado
Santiago Delgado-Tirado
CMClaudia Marino
Claudia Marino
YQYakeel T. Quiroz
Yakeel T. Quiroz

1 November 2012 in Neuron
Verified
Journal Article
Closed access
FSFrancisco Sotres-Bayon
Francisco Sotres-Bayon
DSDemetrio Sierra-Mercado
Demetrio Sierra-Mercado
EPEnmanuelle Pardilla-Delgado
Enmanuelle Pardilla-Delgado
GQGregory J. Quirk
Gregory J. Quirk

5 April 2022 in Proceedings of the National Academy of Sciences of the United States of America
Verified
Journal Article
Open access
EGEdmarie Guzmán-Vélez
Edmarie Guzmán-Vélez
IDIbai Diez
Ibai Diez
DSDorothee Schoemaker
Dorothee Schoemaker
EPEnmanuelle Pardilla-Delgado
Enmanuelle Pardilla-Delgado
CVClara Vila-Castelar
Clara Vila-Castelar
YQYakeel T. Quiroz
Yakeel T. Quiroz
SIGNIFICANCE: Amyloid-β and tau, hallmark pathologies of Alzheimer’s disease (AD), are hypothesized to spread through brain functional networks that are critical for neural communication. Using high-resolution network analyses and positron emission tomography, we showed that greater tau burden was related to functional dysconnectivity of regions associated with memory function and increased connectivity of structures that are important for integrating information in cognitively unimpaired Presenilin-1 E280A carriers, who will develop early-onset AD dementia. These findings enlighten how brain pathology relates to distinct patterns of functional connectivity in regions that are essential for memory and information processing. Elucidating how brain pathology alters functional connections before individuals experience cognitive impairment could help detect AD early and predict disease progression and dementia risk.

1 January 2017 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
EPEnmanuelle Pardilla-Delgado
Enmanuelle Pardilla-Delgado
JPJessica D. Payne
Jessica D. Payne

1 January 2021 in NeuroImage: Clinical
Verified
Journal Article
Open access
VGValentina Ghisays
Valentina Ghisays
FLFrancisco Lopera
Francisco Lopera
DGDhruman D. Goradia
Dhruman D. Goradia
HPHillary D. Protas
Hillary D. Protas
MMMichael H. Malek-Ahmadi
Michael H. Malek-Ahmadi
EREric M. Reiman
Eric M. Reiman
In contrast to sporadic Alzheimer’s disease, autosomal dominant Alzheimer’s disease (ADAD) is associated with greater neuropathological evidence of cerebellar amyloid plaque (Aβ) deposition. In this study, we used positron emission tomography (PET) measurements of fibrillar Aβ burden to characterize the presence and age at onset of cerebellar Aβ deposition in cognitively unimpaired (CU) Presenilin-1 (PSEN1) E280A mutation carriers from the world’s largest extended family with ADAD. 18F florbetapir and 11C Pittsburgh compound B (PiB) PET data from two independent studies – API ADAD Colombia Trial (NCT01998841) and Colombia-Boston (COLBOS) longitudinal biomarker study were included. The tracers were selected independently by the respective sponsors prior to the start of each study and used exclusively throughout. Template-based cerebellar Aβ-SUVR (standard-uptake value ratios) using a known-to-be-spared pons reference region (cerebellar SUVR_pons), to a) compare 28–56-year-old CU carriers and non-carriers; b) estimate the age at which cerebellar SUVR_pons began to differ significantly in carrier and non-carrier groups; and c) characterize in carriers associations with age, cortical SUVR_pons, delayed recall memory, and API ADAD composite score. Florbetapir and PiB cerebellar SUVR_pons were significantly higher in carriers than non-carriers (p < 0.0001). Cerebellar SUVR_pons began to distinguish carriers from non-carriers at age 34, 10 years before the carriers’ estimated age at mild cognitive impairment onset. Florbetapir and PiB cerebellar SUVR_pons in carriers were positively correlated with age (r = 0.44 & 0.69, p < 0.001), cortical SUVR_pons (r = 0.55 & 0.69, p < 0.001), and negatively correlated with delayed recall memory (r = −0.21 & −0.50, p < 0.05, unadjusted for cortical SUVR_pons) and API ADAD composite (r = −0.25, p < 0.01, unadjusted for cortical SUVR_pons in florbetapir API ADAD cohort). This PET study provides evidence of cerebellar Aβ plaque deposition in CU carriers starting about a decade before the clinical onset of ADAD. Additional studies are needed to clarify the impact of using a cerebellar versus pons reference region on the power to detect and track ADAD changes, even in preclinical stages of this disorder.

31 January 2017 in Journal of Visualized Experiments
Verified
Journal Article
Closed access
PDF file
EPEnmanuelle Pardilla-Delgado
Enmanuelle Pardilla-Delgado
JPJessica D. Payne
Jessica D. Payne
Here we present the Deese, Roediger and McDermott (DRM) task, a tool to study false memories in the laboratory. Subjects...